Your session is about to expire
← Back to Search
i-STAND for Sedentary Lifestyle (HART Trial)
HART Trial Summary
This trial is testing a novel intervention to reduce sitting time in older adults, with the goal of improving health. The study design is a randomized control trial, with participants assigned to either the intervention or a control group. After 6 months, the intervention group will be further randomized so that half continue with the intervention and the other half receive no further intervention. All participants will be followed for 12 months.
HART Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHART Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HART Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any vacant places within this research project for prospective trial participants?
"As per statistics on clinicaltrials.gov, recruitment for this medical trial has been suspended since it was last updated in May 6th 2022; however, there are 18 other trials actively looking for participants at the present moment. This study's first listing occurred on February 5th 2019."
To whom is this research prospect available?
"This clinical trial aims to enrol 283 patients, aged between sixty and eighty-nine who have a sedentary lifestyle. The protocols demand that the participant should be of any gender or racial background from within the KPWA region with a BMI ranking higher than 30 but lower than 50 kg/m2. Additionally, they must possess the capability to walk one block while also being literate in English without having any vision impediments, utilizing an assistive device or cognitive impairments as judged by study personnel during phone screening stages. Furthermore, participants must agree to wear a specified device (activPAL) for twelve months duration if selected into this research project"
Is the current research initiative accepting participants over forty years of age?
"The age range for patients eligible to join this trial are 60-89, however there are additional trials specifically recruiting minors and seniors."
Share this study with friends
Copy Link
Messenger